Translational research is now at the forefront of most researchers minds. It has never been more crucial for R&D companies and for the benefit of society, to shorten the time to market for new drug and healthcare technologies.

ON Helix, brought to you by One Nucleus is our translational research conference for everyone in the life science sector.
ON Helix is a one day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).

It presents the UK landscape of the business environment, funding, scientific and clinical research excellence and will be a unique knowledge-sharing environment between academia and business:

• Session 1: Translating Your Research; What Works Better? Asset or Pipeline?
• Session 2: The Future of Medicines: New Technologies
• Session 3: Debate: Do Charities Make the Best Investors?

We are delighted to announce our Keynote Speakers:

• Sharon Vosmek, CEO, Astia
• David Tapolczay, CEO, MRC Technology
• Sara-Jane Dunn, Microsoft
• Pete Jackson, The AMR Centre

Click to view our 2017 programme for ON Helix.

The conference will commence with our Welcome Reception and Summer BioNewsRound Award on 12 July, more information can be found here.

Please click here to view our delegate rates and here for more information on exhibiting at ON Helix.

To register, please click here.

A 10% discount is available to MediWales members. Contact Isabelle for more information.